---
layout: splash
title: 삼성바이오로직스 (207940)
excerpt: 삼성바이오로직스의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
- 고PER
keywords: 삼성바이오로직스, 207940
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 932,000 | <span style="color: cornflowerblue">-0.7<small>%</small></span> | P:의약품 | 77.3 | 6.8 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | P:의약품 / 기초 의약물질 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 바이오의약품 |
| <span style="white-space:nowrap;">**상장**</span> | KOSPI / 2016년 11월 10일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 임존종보 (Rim John Chongbo) |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.samsungbiologics.com](http://www.samsungbiologics.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 08&#x2011;14 | | [반기보고서 (2024.06)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240814003571){:target="_blank"} |
|  | | [지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240814002757){:target="_blank"} |
|  | | [[기재정정]투자판단관련주요경영사항              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240814801059){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![207940](/stock/images/207940.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 932,000 | <span style="color: cornflowerblue">-0.7<small>%</small></span> | <span style="color: cornflowerblue">-2.9<small>%</small></span> | <span style="color: tomato">9.5<small>%</small></span> | <span style="color: tomato">19.6<small>%</small></span> | <span style="color: tomato">13.9<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">17.3<small>%</small></span> | 25.7<small>%</small> | 0.68 | -15.4<small>%</small> | -7.1<small>%</small> | -1.1 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 77.3 | 6.8 | - | 고PER |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/207940/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=207940){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A207940&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=207940){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/207940){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/207940/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![207940](/stock/images/207940_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 17.3<small>%</small> | 25.7<small>%</small> | 0.68 | -15.4<small>%</small> | -7.1<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 20.8<small>%</small> | 25.4<small>%</small> | 0.82 | -18.2<small>%</small> | -5.9<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 3.1<small>%</small> | 15.4<small>%</small> | 0.20 | -8.6<small>%</small> | -3.5<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 17.1<small>%</small> | 18.8<small>%</small> | 0.91 | -11.9<small>%</small> | -4.7<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 12.2<small>%</small> | 19.9<small>%</small> | 0.61 | -13.4<small>%</small> | -6.5<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 16.4<small>%</small> | 19.1<small>%</small> | 0.86 | -9.9<small>%</small> | -4.8<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 11.6<small>%</small> | 19.1<small>%</small> | 0.61 | -13.7<small>%</small> | -5.2<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 6.4<small>%</small> | 18.4<small>%</small> | 0.35 | -14.5<small>%</small> | -4.3<small>%</small> |
| MACD[^fn_tech_metric_macd] | 10.0<small>%</small> | 21.0<small>%</small> | 0.47 | -14.8<small>%</small> | -6.2<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![207940](/stock/images/207940_corr.png){: .align-center}

|       | [한화](/000880/) | [HLB](/028300/) | [메리츠금융지주](/138040/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [삼성물산](/028260/) | [에이비엘바이오](/298380/) | [대웅](/003090/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![207940](/stock/images/207940_2x.png){: .align-center}


> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info}

{% include commons/footnotes.md %}